Literature DB >> 31078680

Interspecies differences in perfluoroalkyl substances (PFAS) toxicokinetics and application to health-based criteria.

Daniella M Pizzurro1, Mara Seeley1, Laura E Kerper1, Barbara D Beck2.   

Abstract

Toxicokinetics are important for extrapolating health effects and effect levels observed in laboratory animals to humans for purposes of establishing health-based criteria. We conducted a comprehensive review of key absorption, distribution, metabolism, and excretion (ADME) parameters across different mammalian species for five perfluoroalkyl substances (PFAS) and discussed how these data can be used to inform human health risk assessment of these substances. Our analysis revealed several notable differences among the different PFAS regarding species- and substance-specific tissue partitioning, half-life, and transfer to developing offspring via the placenta or lactation, as well as highlighted data gaps for certain substances. We incorporated these observations in an analysis of whether health-based values for specific PFAS can be applied to other PFAS of differing chain length or toxicological mode of action. Overall, our analysis provides one of the first syntheses of available empirical PFAS toxicokinetic data to facilitate interpreting human relevance of animal study findings and developing health-based criteria for PFAS from such studies.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  PFAS; PFBA; PFBS; PFHxS; PFOA; PFOS; Perfluorinated; Toxicokinetics

Mesh:

Substances:

Year:  2019        PMID: 31078680     DOI: 10.1016/j.yrtph.2019.05.008

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  19 in total

1.  In vitro activity of a panel of per- and polyfluoroalkyl substances (PFAS), fatty acids, and pharmaceuticals in peroxisome proliferator-activated receptor (PPAR) alpha, PPAR gamma, and estrogen receptor assays.

Authors:  Nicola Evans; Justin M Conley; Mary Cardon; Phillip Hartig; Elizabeth Medlock-Kakaley; L Earl Gray
Journal:  Toxicol Appl Pharmacol       Date:  2022-06-22       Impact factor: 4.460

2.  Commentary: cumulative risk assessment of perfluoroalkyl carboxylic acids and perfluoralkyl sulfonic acids: what is the scientific support for deriving tolerable exposures by assembling 27 PFAS into 1 common assessment group?

Authors:  Thomas Colnot; Wolfgang Dekant
Journal:  Arch Toxicol       Date:  2022-08-17       Impact factor: 6.168

3.  The role of maternal high fat diet on mouse pup metabolic endpoints following perinatal PFAS and PFAS mixture exposure.

Authors:  Emily S Marques; Juliana Agudelo; Emily M Kaye; Seyed Mohamad Sadegh Modaresi; Marisa Pfohl; Jitka Bečanová; Wei Wei; Marianne Polunas; Michael Goedken; Angela L Slitt
Journal:  Toxicology       Date:  2021-08-28       Impact factor: 4.571

Review 4.  Immunomodulation and exposure to per- and polyfluoroalkyl substances: an overview of the current evidence from animal and human studies.

Authors:  Evangelia Antoniou; Thomas Colnot; Maurice Zeegers; Wolfgang Dekant
Journal:  Arch Toxicol       Date:  2022-06-13       Impact factor: 6.168

5.  Bioavailability of inhaled or ingested PFOA adsorbed to house dust.

Authors:  Åsa Gustafsson; Bei Wang; Per Gerde; Åke Bergman; Leo W Y Yeung
Journal:  Environ Sci Pollut Res Int       Date:  2022-06-14       Impact factor: 5.190

6.  Legacy and Novel Per- and Polyfluoroalkyl Substances in Juvenile Seabirds from the U.S. Atlantic Coast.

Authors:  Anna R Robuck; Mark G Cantwell; James P McCord; Lindsay M Addison; Marisa Pfohl; Mark J Strynar; Richard McKinney; David R Katz; David N Wiley; Rainer Lohmann
Journal:  Environ Sci Technol       Date:  2020-10-07       Impact factor: 9.028

7.  Unveiling the binding mode of perfluorooctanoic acid to human serum albumin.

Authors:  Lorenzo Maso; Matteo Trande; Stefano Liberi; Giulia Moro; Elise Daems; Sara Linciano; Frank Sobott; Sonia Covaceuszach; Alberto Cassetta; Silvano Fasolato; Ligia M Moretto; Karolien De Wael; Laura Cendron; Alessandro Angelini
Journal:  Protein Sci       Date:  2021-03-05       Impact factor: 6.725

8.  Developmental toxicity of Nafion byproduct 2 (NBP2) in the Sprague-Dawley rat with comparisons to hexafluoropropylene oxide-dimer acid (HFPO-DA or GenX) and perfluorooctane sulfonate (PFOS).

Authors:  Justin M Conley; Christy S Lambright; Nicola Evans; Elizabeth Medlock-Kakaley; Donna Hill; James McCord; Mark J Strynar; Leah C Wehmas; Susan Hester; Denise K MacMillan; L Earl Gray
Journal:  Environ Int       Date:  2021-12-22       Impact factor: 9.621

9.  Co-exposure to PCB126 and PFOS increases biomarkers associated with cardiovascular disease risk and liver injury in mice.

Authors:  Pan Deng; Chunyan Wang; Banrida Wahlang; Travis Sexton; Andrew J Morris; Bernhard Hennig
Journal:  Toxicol Appl Pharmacol       Date:  2020-10-20       Impact factor: 4.219

10.  Quantitative Chemical Proteomics Reveals Interspecies Variations on Binding Schemes of L-FABP with Perfluorooctanesulfonate.

Authors:  Jiajun Han; Jesse Fu; Jianxian Sun; David Ross Hall; Diwen Yang; Donovan Blatz; Keith Houck; Carla Ng; Jon Doering; Carlie LaLone; Hui Peng
Journal:  Environ Sci Technol       Date:  2021-06-16       Impact factor: 11.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.